The patient has extensive disease, and requires palliative radiation to the scapular area (proximal to the brachial plexus) in a region overlapping with a prior palliative course. 

Is trastuzumab deruxtecan (T-Dxd) contraindicated during palliative radiation to a non-CNS site, or can it be safely continued during radiation to the shoulder area?